ELOVL2 anticorps (N-Term)

N° du produit ABIN653138

Il existe 1 publication pour ce produit. L’anticorps anti-ELOVL2 Polyclonal Lapin est utilisé pour la détection de ELOVL2 dans des échantillons de Humain. Il a été validé pour WB, FACS et IHC (p).

Aperçu rapide pour ELOVL2 anticorps (N-Term) (ABIN653138)

Antigène: ELOVL2 (ELOVL Fatty Acid Elongase 2 (ELOVL2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ELOVL2 est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: RB23770

Détail du produit anti-ELOVL2 anticorps

Épitope: AA 1-27, N-Term

Homologie: M

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This ELOVL2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-27 amino acids from the N-terminal region of human ELOVL2.

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Date de péremption: 6 months

Références pour anticorps anti-ELOVL2 (ABIN653138)

Meller, VAN Ellen, Gevensleben, Bicker, Hankeln, Gorr, Sailer, Dröge, Schröck, Bootz, Schröck, Perner, Dietrich, Kristiansen: "Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma Patients." dans: Anticancer research, Vol. 36, Issue 12, pp. 6235-6241, (2017) (PubMed).

Détails sur ELOVL2

Antigène: ELOVL2 (ELOVL Fatty Acid Elongase 2 (ELOVL2))

Autre désignation: ELOVL2

Sujet: ELOVL2 could be implicated in tissue-specific synthesis of very long chain fatty acids and sphingolipids. This protein may catalyze one or both of the reduction reaction in fatty acid elongation, i.e., conversion of beta-ketoacyl CoA to beta-hydroxyacyl CoA or reduction of trans-2-enoyl CoA to the saturated acyl CoA derivative (By similarity).

Poids moléculaire: 34585

ID gène: 54898

NCBI Accession: NP_060240

UniProt: Q9NXB9